XML 52 R36.htm IDEA: XBRL DOCUMENT v3.25.0.1

Stock Options (Tables)

12 Months Ended

Dec. 31, 2024

Stock Options and Restricted Stock Units

Schedule of weighted-average fair value of the options granted, and weighted-average assumptions

​

​	​	​	​	​	​	​	​
​	​	For the Year Ended December 31,
​	​	2024		​	2023
​	​	​	​	​	​	​	​
Weighted average fair value of options granted		$	32.07		$	2.56	​
Risk-free interest rate		​	4.40	%		4.34	%
Expected term (years)		​	6.0	​		6.0	​
Expected volatility factor		​	87.69	%		75.35	%
Expected dividends		​	None	​		None	​

Equity Plans

Stock Options and Restricted Stock Units

Schedule of stock option activity

​

​	​	​	​	​	​	​	​	​	​	​
​		​		​	​		Weighted-Average		​	​
​	​	​	​	Weighted -Average		​	Remaining	​	​	​
​	​	Number of	​	Exercise		​	Contractual Term	​	Aggregate
​	​	Options	​	Price		​	(years)	​	Intrinsic Value
Outstanding at January 1, 2024		5,339,162	​	$	3.22		6.38	​	$	28,640,009
Granted		-	​		-		​	​	​	​
Exercised		(2,169,968)	​		2.54		​	​	​	​
Forfeited/Expired		(4,001)	​		6.96		​	​	​	​
Outstanding at December 31, 2024		3,165,193	​	$	3.67		6.32	​	$	113,458,326
​	​	​	​	​	​	​	​	​	​	​
Exercisable at December 31, 2024		1,673,966	​	$	2.54		5.51	​	$	61,901,891
​	​	​	​	​	​	​	​	​	​	​
Vested and Expected to vest at December 31, 2024		3,165,193	​	$	3.67		6.32	​	$	113,458,326

​

​	​	​	​	​	​	​	​	​	​	​
​		​		​	​		Weighted-Average		​	​
​	​	​	​	Weighted – Average		​	Remaining	​	​	​
​	​	Number of	​	Exercise		​	Contractual Term	​	Aggregate
​	​	Options	​	Price		​	(years)	​	Intrinsic Value
​	​	​	​	​	​	​	​	​	​	​
Outstanding at January 1, 2023		6,690,490	​	$	3.09		7.19	​	$	5,989,709
Granted*		25,000	​		3.31			​
Exercised		(1,287,462)	​		2.37			​
Forfeited/Expired		(88,866)	​		6.27			​
Outstanding at December 31, 2023		5,339,162	​	$	3.22		6.38	​	$	28,640,009
​	​	​	​	​	​	​	​	​	​	​
Exercisable at December 31, 2023		3,475,780	​	$	2.18		6.40	​	$	22,237,334
​	​	​	​	​	​	​	​	​	​	​
Vested and Expected to vest at December 31, 2023		5,339,162	​	$	3.22		6.38	​	$	28,640,009

​

* Includes 25,000 stock options granted to a non-employee member of the Company’s advisory board.

​

​	​	​	​	​	​	​	​	​	​	​
​		​		​			Weighted-Average		​
​	​	​	​	Weighted - Average		​	Remaining	​	​	​
​	​	Number of	​	Exercise		​	Contractual Term	​	Aggregate
​	​	Options	​	Price		​	(years)	​	Intrinsic Value
​	​	​	​	​	​	​	​	​	​	​
Outstanding at January 1, 2024		923,571	​	$	3.41		8.76	​	$	4,786,252
Granted		268,500	​		42.57		​	​	​	​
Exercised		(336,264)	​		3.44		​	​	​	​
Forfeited/Expired		(13,536)	​		4.84		​	​	​	​
Outstanding at December 31, 2024		842,271	​	$	15.86		8.46	​	$	20,847,471
​	​	​	​	​	​	​	​	​	​	​
Exercisable at December 31, 2024		314,244	​	$	3.32		7.73	​	$	11,374,251
​	​	​	​	​	​	​	​	​	​	​
Vested and Expected to vest at December 31, 2024		842,271	​	$	15.86		8.46	​	$	20,847,471

​

​	​	​	​	​	​	​	​	​	​	​
​		​		​			Weighted-Average		​	​
​	​	​	​	Weighted - Average		​	Remaining	​	​	​
​	​	Number of	​	Exercise		​	Contractual Term	​	Aggregate
​	​	Options	​	Price		​	(years)	​	Intrinsic Value
​	​	​	​	​	​	​	​	​	​	​
Outstanding at January 1, 2023		1,027,500	​	$	3.46		9.75	​	$	-
Granted		3,000	​		13.05			​
Exercised		(63,595)	​		4.59			​
Forfeited/Expired		(43,334)	​		3.41			​
Outstanding at December 31, 2023		923,571	​	$	3.41		8.76	​	$	4,786,252
​	​	​	​	​	​	​	​	​	​	​
Exercisable at December 31, 2023		386,209	​	$	3.34		8.74	​	$	2,023,601
​	​	​	​	​	​	​	​	​	​	​
Vested and Expected to vest at December 31, 2023		923,571	​	$	3.41		8.76	​	$	4,786,252

Restricted Stock Units

Stock Options and Restricted Stock Units

Summary of restricted stock under the company's plan

​

​	​	​	​	​	​
​		​		Weighted-
​	​	Number of	​	Average
​	​	Restricted Stock	​	Grant Date
​	​	Units	​	Fair Value
​	​	​	​	​	​
Unvested at January 1, 2024	​	749,756	​	$	5.77
Granted		549,079	​	​	40.61
Vested		(48,761)	​		8.42
Forfeited/Expired		(995)	​		8.29
Unvested at December 31, 2024		1,249,079	​	$	20.98

​

​	​	​	​	​	​
​		​		Weighted-
​	​	Number of	​	Average
​	​	Restricted Stock	​	Grant Date
​	​	Units	​	Fair Value
​	​	​	​	​	​
Unvested at January 1, 2023	​	700,000	​	$	5.59
Granted	​	49,756	​	​	8.29
Vested		-		​	-
Forfeited/Expired		-		​	-
Unvested at December 31, 2023		749,756	​	$	5.77

X

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	inod_StockOptionsLineItems
Namespace Prefix:	inod_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Subparagraph (f)(2)
-Name Accounting Standards Codification
-Paragraph 2
-Section 50
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.

+ References

No definition available.

+ Details

Name:	us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	us-gaap_PlanNameAxis=inod_EquityPlansMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: